Perspectives in immunotherapy: meeting report from the “Immunotherapy Bridge 2018” (28–29 November, 2018, Naples, Italy)

Immunotherapy is now widely established as a potent and effective treatment option across several types of cancer. However, there is increasing recognition that not all patients respond to immunotherapy, focusing attention on the immune contexture of the tumor microenvironment (TME), drivers of the...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Immunother Cancer
Autori principali: Ascierto, Paolo A., Bifulco, Carlo, Buonaguro, Luigi, Emens, Leisha A., Ferris, Robert L., Fox, Bernard A., Delgoffe, Greg M., Galon, Jérôme, Gridelli, Cesare, Merlano, Marco, Nathan, Paul, Odunsi, Kunle, Okada, Hideho, Paulos, Chrystal M., Pignata, Sandro, Schalper, Kurt A., Spranger, Stefani, Tortora, Giampaolo, Zarour, Hassane, Butterfield, Lisa H., Puzanov, Igor
Natura: Artigo
Lingua:Inglês
Pubblicazione: BioMed Central 2019
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6884742/
https://ncbi.nlm.nih.gov/pubmed/31783779
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0798-3
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi